Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.

Smith & Nephew Snats (SNN) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart


See More
  • Market Capitalization, $K 12,683,580
  • Shares Outstanding, K 443,020
  • Annual Sales, $ 4,634 M
  • Annual Income, $ 410 M
  • 36-Month Beta 0.78
  • Price/Sales 2.74
  • Price/Book 3.23

Price Performance

See More
Period Period Low Period High Performance
26.97 +7.34%
on 11/14/16
28.95 unch
on 12/06/16
+0.52 (+1.83%)
since 11/04/16
26.97 +7.34%
on 11/14/16
33.61 -13.86%
on 09/22/16
-4.75 (-14.09%)
since 09/06/16
26.97 +7.34%
on 11/14/16
36.11 -19.83%
on 12/30/15
-4.92 (-14.53%)
since 12/04/15

Most Recent Stories

More News
U.S. Uterine Fibroids Market Worth US $273.6 Million by the end of 2024: Rising Prevalence of Fibroid to Ensure Uptake, Says TMR

The U.S. Uterine Fibroids Market shows a strong presence of players. The top three players in the market are Boston Scientific Corporation, Smith & Nephew, and Hologic, Inc., who hold a share of nearly...

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2016

Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on November 16th and 17th, featuring live webcast presentations from international companies with...

Enabling Improved Patient Outcomes with Smith & Nephew's Pioneering Episode of Care Assurance Program (eCAP)

Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, announces that the U.S. health and wellness organization, Provider PPI LLC, has adopted its Episode of Care Assurance Program...

Michael Kors Appoints Robin Freestone to Board of Directors

Michael Kors Holdings Limited (NYSE:KORS) (the "Company"), a global luxury lifestyle brand, today announced that Robin Freestone has been appointed to the Company's Board of Directors, effective...

Global Extremity Reconstruction Market Worth USD 3,041 Million by 2022 - Analysis, Technologies & Forecasts Report 2014-2022 - Vendors: DePut Synthes, Smith & Nephew, Stryker - Research and Markets

Research and Markets has announced the addition of the "Extremity Reconstruction Market By Type, By Biomaterials - Global Opportunity Analysis and Industry Forecast, 2014 - 2022" report to...

ConforMIS Names Industry Veteran Mark Augusti President and Chief Executive Officer

ConforMIS Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy, announced today that...

Research and Markets - Global Endoscopy Devices Market, 2022: Major Players Include J&J, Olympus, Medtronic, Boston Scientific, Stryker, Smith & Newphew, Karl Storz & B. Brain Melsungen

Research and Markets has announced the addition of the "Endoscopy Devices Global market - Forecast to 2022" [] report to their offering....

Watch for Smith & Nephew to Potentially Rebound After Falling 1.17% Yesterday

Smith & Nephew (NYSE:SNN) traded in a range yesterday that spanned from a low of $30.10 to a high of $30.35. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $30.62...

Downgrade Alert for Smith & Nephew (SNN)

Smith & Nephew (NYSE:SNN) was downgraded from Buy to Hold at Berenberg today. The stock closed yesterday at $31.41 on volume of 870,000 shares, above average daily volume of 302,000. In the past 52 weeks,...

Research and Markets - Global Cannulas Market Growth at CAGR of 6.73%, 2016-2020: Key Vendors are Boston Scientific, Edward Lifesciences, MAQUET, Medtronic, Smith & Nephew & Terumo

DUBLIN, October 3, 2016 /PRNewswire/ --

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative...

See More

Support & Resistance

2nd Resistance Point 28.83
1st Resistance Point 28.66
Last Price 28.95
1st Support Level 28.40
2nd Support Level 28.31

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.